Results 1 to 10 of about 35,415 (154)

Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation [PDF]

open access: goldiScience, 2021
Summary: It has been suggested that aberrant activation of glycogen synthase kinase-3-beta (GSK-3β) can trigger abnormal tau hyperphosphorylation and aggregation, which ultimately leads to neuronal/synaptic damage and impaired cognition in Alzheimer ...
Ana Claudia Amaral   +15 more
doaj   +2 more sources

The rs140668532 SNP in GSK-3β gene as a potential biomarker for Alzheimer’s disease: Insights from computational modeling [PDF]

open access: yesToxicology Reports
Glycogen synthase kinase-3 beta (GSK-3β) is well recognized for its role in diverse physiological processes, including apoptosis, mitochondrial function, and gene transcription regulation.
İrem Gülfem Albayrak   +1 more
doaj   +2 more sources

The Key Roles of GSK-3β in Regulating Mitochondrial Activity

open access: goldCellular Physiology and Biochemistry, 2017
Glycogen synthase kinase-3β (GSK-3β), a serine/threonine protein kinase, has been reported to show essential roles in molecular pathophysiology of many diseases.
Kai Yang   +9 more
doaj   +2 more sources

Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration

open access: yesEBioMedicine, 2022
Summary: Background: Glycogen synthase kinase-3β (GSK-3β) is one of the most effective kinases in promoting tau hyperphosphorylation and accumulation in Alzheimer's disease (AD).
Qiuzhi Zhou   +9 more
doaj   +1 more source

Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Although many studies have shown glycogen synthase kinase-3β (GSK-3β) was associated with type 2 diabetes mellitus (T2DM) and implicated with a wide range of cancers, the role of GSK-3β in hepatocellular carcinoma(HCC) and the correlation ...
Guoliang Qiao   +4 more
doaj   +1 more source

Pharmacologically Inhibiting Glycogen Synthase Kinase-3β Ameliorates Renal Inflammation and Nephrotoxicity in an Animal Model of Cisplatin-Induced Acute Kidney Injury

open access: yesBiomedicines, 2021
The adverse effect of cisplatin administration causes acute kidney injury (AKI) following renal inflammation and nephrotoxicity, characterized by proximal tubular cell apoptosis and necrosis.
Chung-Hsi Hsing   +6 more
doaj   +1 more source

New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis [PDF]

open access: yesPeerJ, 2023
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine kinase widely expressed in various tissues and organs. Unlike other kinases, GSK-3 is active under resting conditions and is inactivated upon stimulation. In mammals, GSK-3 includes GSK-3 α and GSK-
Shenjin Lai   +3 more
doaj   +2 more sources

Polarized regulation of glycogen synthase kinase-3β is important for glioma cell invasion. [PDF]

open access: yesPLoS ONE, 2013
Glioma malignancy greatly depends on its aggressive invasion. The establishment of cell polarity is an important initial step for cell migration, which is essential for cell-directional translocation.
Qifei Zou   +3 more
doaj   +1 more source

GSK-3β, a pivotal kinase in Alzheimer disease [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2014
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of AD is considered to be multifactorial as only a negligible percentage of cases have a familial or genetic origin. Glycogen synthase kinase-3 (GSK-3) is regarded as a critical molecular link between the two histopathological hallmarks of the disease, namely senile ...
Maria eLLorens-Martin   +7 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy